Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196391 · ClinicalTrials.gov registry record · Phase 2
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
A Phase 2 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
NCT00196391: Completed Phase 2 study, sponsored by Duramed Research.
NCT00196391 is a Phase 2 study that has completed, run by Duramed Research. The registered enrollment target is 180 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00196391, a Phase 2 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
Study Summary
This is a multicenter trial to compare the effectiveness of 4 doses of DR-2021 with placebo and oral micronized progesterone in inducing withdrawal bleeding in women with secondary amenorrhea.
Interventions
- DRUG DR-2021a
- DRUG DR-2021b
- DRUG DR-2021c
- DRUG DR-2021d
- DRUG DR-2021e
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
What the finished NCT00196391 record still lists
NCT00196391 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher).
The record links to 0 conditions, and to 5 interventions - of which DR-2021a is the first listed.
NCT00196391 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00196391 about?
NCT00196391 is a clinical study titled "A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea". This is a multicenter trial to compare the effectiveness of 4 doses of DR-2021 with placebo and oral micronized progesterone in inducing withdrawal bleeding in women with secondary amenorrhea.
What is the current status of trial NCT00196391?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2005-09. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00196391?
The interventions under investigation include: DR-2021a (DRUG), DR-2021b (DRUG), DR-2021c (DRUG), DR-2021d (DRUG), DR-2021e (DRUG).
Who is sponsoring clinical trial NCT00196391?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00196391's enrollment target sits among peer trials
180 365th of 2000 higher than 1,610 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia